ClinicaliQ Trial Snapshot
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants — Active Not Recruiting • Phase I • NCT07286682.
- A safety and dose study of new drug UCB5285 in healthy people, including Japanese volunteers.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this study is to evaluate the safety and tolerability of single ascending doses of UCB5285 in healthy study participants, including healthy Japanese study participants Conditions: Healthy Participants Interventions: UCB5285, Placebo Lead Sponsor: UCB Biopharma SRL Planned Enrollment: 80 participants